Indirubin and Indigo Are Potent Aryl Hydrocarbon Receptor Ligands Present in Human Urine
Open accessAbstract
Aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that regulates genes involved in xenobiotic metabolism, cellular proliferation, and differentiation. Numerous xenobiotic and biological compounds are known to interact with AhR, but it remains an orphan receptor, because its physiological ligand is unknown. We identified AhR ligands in human urine using a yeast AhR signaling assay and then characterized their properties. Two ligands, indirubin and indigo, were both present at average concentrations of approximately 0.2 nm in the urine of normal donors. Indirubin was also detected in fetal bovine serum and contributed half of the total AhR ligand activity. The activities of indirubin and indigo were comparable with or more potent than that of the archetypal ligand, 2,3,7,8-tetrachlorodibenzo-p-dioxin, in yeast AhR activation assays. We suggest that the endogenous levels and potencies of indirubin and indigo are such that they activate AhR-mediated signaling mechanisms in vivo.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Indirubin demonstrated the strongest binding to AHR among these ligands, consistent with previous reports.
“Nevertheless, Indirubin demonstrated the strongest binding to AHR among these ligands, consistent with previous reports45,46.”
From Structural basis for the ligand-dependent activation of heterodimeric AHR-ARNT complex (2025) · cites this paper as [45]
Cites
The Aryl Hydrocarbon Receptor Complex
Hankinson, O. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.001515 · Cited by 1,649 · see citing works
Hoessel, R., Leclerc, S., Endicott, J., Nobel, M. E. M., Lawrie, A. M., Tunnah, P., Leost, M., Damiens, E., Marie, D., Marko, D., et al. (1999) · Nature Cell Biology · doi:10.1038/9035 · Cited by 816 · see citing works
Pohjanvirta, R., & Tuomisto, J. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06814-0 · Cited by 472 · see citing works
Kolluri, S. K., Weiss, C., Koff, A., & Göttlicher, M. (1999) · Genes & Development · doi:10.1101/gad.13.13.1742 · Cited by 364 · see citing works
Puga, A., Barnes, S., Dalton, T. P., Chang, C., Knudsen, E. S., & Maier, M. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2943 · Cited by 315 · see citing works
Oxidation of Indole by Cytochrome P450 Enzymes
Gillam, E. M. J., Notley, L. M., Cai, H., De Voss, J. J., & Guengerich, F. P. (2000) · Biochemistry · doi:10.1021/bi001229u · Cited by 313 · see citing works
Lipoxin A4: A New Class of Ligand for the Ah Receptor
Schaldach, C., Riby, J. E., & Bjeldanes, L. F. (1999) · Biochemistry · doi:10.1021/bi982861e · Cited by 265 · see citing works
A Direct Interaction between the Aryl Hydrocarbon Receptor and Retinoblastoma Protein
Ge, N.-L., & Elferink, C. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22708 · Cited by 258 · see citing works
Sinal, C. J., & Bend, J. R. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.4.590 · Cited by 256 · see citing works
Molecular biology of the aromatic hydrocarbon (dioxin) receptor
Okey, A. B., Riddick, D. S., & Harper, P. A. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90316-6 · Cited by 236 · see citing works
Ah Receptor, a Novel Ligand-Activated Transcription Factor
Sogawa, K., & Fujii-Kuriyama, Y. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021864 · Cited by 204 · see citing works
Carcinogenicity of TCDD: Experimental, Mechanistic, and Epidemiologic Evidence
Huff, J., Lucier, G. W., & Tritscher, A. M. (1994) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.002015 · Cited by 169 · see citing works
Wei, Y., Helleberg, H., Rannug, U., & Rannug, A. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00111-7 · Cited by 157 · see citing works
Formation of Indigo by Recombinant Mammalian Cytochrome P450
Gillam, E. M. J., Aguinaldo, A. M. A., Notley, L. M., Kim, D., Mundkowski, R. G., Volkov, A. A., Arnold, F. H., Souček, P., Voss, J. J. D., & Guengerich, F. P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1702 · Cited by 134 · see citing works
7-Ketocholesterol Is an Endogenous Modulator for the Arylhydrocarbon Receptor
Savouret, J., Antenos, M., Quesne, M., Xu, J., Milgröm, E., & Casper, R. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005988200 · Cited by 125 · see citing works
Hayatsu, H. (1992) · Journal of Chromatography A · doi:10.1016/0021-9673(92)80095-c · Cited by 120 · see citing works
Miller, C. A. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8769 · Cited by 114 · see citing works
Self-citationRegulation of CYP1A1 by Indolo[3,2-b]carbazole in Murine Hepatoma Cells
Chen, Y., Riby, J. E., Srivastava, P. K., Bartholomew, J. C., Denison, M. S., & Bjeldanes, L. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22548 · Cited by 108 · see citing works
Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor
Reiners, J. J. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1561 · Cited by 108 · see citing works
The presence of genotoxic and bioactive components in indigo dyed fabrics — a possible heatlh risk?
Rannug, U., Bramstedt, H., & Nilsson, U. (1992) · Mutation Research Letters · doi:10.1016/0165-7992(92)90099-4 · Cited by 37 · see citing works
Sapira, J. D., Somani, S. M., Shapiro, A. P., Scheib, E. T., & Reihl, W. (1971) · Metabolism · doi:10.1016/0026-0495(71)90123-5 · Cited by 19 · see citing works
The isolation and identification of indigoid pigments from urine
Jackson, A. H., Jenkins, R. T., Grinstein, M., de Sancovich, A. M. F., & Sancovich, H. A. (1988) · Clinica Chimica Acta · doi:10.1016/0009-8981(88)90330-0 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Denison, M. S., & Nagy, S. R. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135828 · Cited by 1,895 · see citing works
Impact of Natural Products on Developing New Anti-Cancer Agents
Cragg, G. M. L., Grothaus, P. G., & Newman, D. J. (2009) · Chemical Reviews · doi:10.1021/cr900019j · Cited by 1,310 · see citing works
Regulation of the immune response by the aryl hydrocarbon receptor
Gutiérrez-Vázquez, C., & Quintana, F. J. (2018) · Immunity · doi:10.1016/j.immuni.2017.12.012 · Cited by 985 · see citing works
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Murray, I. A., Patterson, A. D., & Perdew, G. H. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3846 · Cited by 889 · see citing works
GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins
Meijer, L., Skaltsounis, A., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M., Ryan, X. P., Vonica, A., Brivanlou, A. H., Dajani, R., et al. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.11.010 · Cited by 814 · see citing works
Functional role of AhR in the expression of toxic effects by TCDD
Mimura, J., & Fujii‐Kuriyama, Y. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00485-3 · Cited by 746 · see citing works
The Search for Endogenous Activators of the Aryl Hydrocarbon Receptor
Nguyen, L. P., & Bradfield, C. A. (2007) · Chemical Research in Toxicology · doi:10.1021/tx7001965 · Cited by 705 · see citing works
Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation
Hubbard, T. D., Murray, I. A., & Perdew, G. H. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.064246 · Cited by 646 · see citing works
DiNatale, B. C., Murray, I. A., Schroeder, J. C., Flaveny, C. A., Lahoti, T. S., Laurenzana, E. M., Omiecinski, C. J., & Perdew, G. H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq024 · Cited by 631 · see citing works
AhR signaling pathways and regulatory functions
Larigot, L., Juricek, L., Dairou, J., & Coumoul, X. (2018) · Biochimie Open · doi:10.1016/j.biopen.2018.05.001 · Cited by 563 · see citing works
Westerink, W. M. A., & Schoonen, W. G. E. J. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.05.014 · Cited by 544 · see citing works
The Aryl Hydrocarbon Receptor in Barrier Organ Physiology, Immunology, and Toxicology
Esser, C., & Rannug, A. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009001 · Cited by 501 · see citing works
Ligand binding and activation of the Ah receptor
Denison, M. S., Pandini, A., Nagy, S. R., Baldwin, E. P., & Bonati, L. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00063-7 · Cited by 485 · see citing works
Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases
Mazanetz, M. P., & Fischer, P. M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2111 · Cited by 459 · see citing works
Understanding the human health effects of chemical mixtures.
Carpenter, D. O., Arcaro, K. F., & Spink, D. C. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110s125 · Cited by 425 · see citing works
The aryl hydrocarbon receptor, more than a xenobiotic‐interacting protein
Barouki, R., Coumoul, X., & Fernández‐Salguero, P. M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.046 · Cited by 398 · see citing works
Polychronopoulos, P., Magiatis, P., Skaltsounis, A., Myrianthopoulos, V., Mikros, E., Tarricone, A., Musacchio, A., Roe, S. M., Pearl, L. H., Leost, M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031016d · Cited by 382 · see citing works
(CONTAM), E. P. O. C. I. T. F. C., Knutsen, H. K., Alexander, J., Barregård, L., Bignami, M., Brüschweiler, B. J., Ceccatelli, S., Cottrill, B., Dinovi, M., Edler, L., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5333 · Cited by 353 · see citing works
Aryl Hydrocarbon Receptor Control of Adaptive Immunity
Quintana, F. J., & Sherr, D. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007823 · Cited by 336 · see citing works
The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment
Shinde, R. S., & McGaha, T. L. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.10.010 · Cited by 331 · see citing works
An introduction to the molecular basics of aryl hydrocarbon receptor biology
Abel, J., & Haarmann‐Stemmann, T. (2010) · Biological Chemistry · doi:10.1515/bc.2010.128 · Cited by 297 · see citing works
A Novel Role for the Dioxin Receptor in Fatty Acid Metabolism and Hepatic Steatosis
Lee, J. H., Wada, T., Febbraio, M., He, J., Matsubara, T., Lee, M. J., Gonzalez, F. J., & Xie, W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.033 · Cited by 277 · see citing works
A ligand for the aryl hydrocarbon receptor isolated from lung
Song, J., Clagett‐Dame, M., Peterson, R. E., Hahn, M. E., Westler, W. M., Siciński, R. R., & DeLuca, H. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232562899 · Cited by 264 · see citing works
Endogenous and Exogenous Ligands of Aryl Hydrocarbon Receptor: Current State of Art
Stejskalová, L., Dvořák, Z., & Pávek, P. (2011) · Current Drug Metabolism · doi:10.2174/138920011795016818 · Cited by 231 · see citing works
Westerink, W. M. A., & Schoonen, W. G. E. J. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.06.017 · Cited by 226 · see citing works
Cytochrome p450 enzymes in the generation of commercial products
Guengerich, F. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd792 · Cited by 223 · see citing works
Guengerich, F. P. (2007) · Springer eBooks · doi:10.1007/0-387-27447-2_10 · Cited by 220 · see citing works
Kawajiri, K., & Fujii-Kuriyama, Y. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.03.038 · Cited by 197 · see citing works
Pocar, P., Fischer, B., Klonisch, T. C., & Hombach‐Klonisch, S. (2005) · Reproduction · doi:10.1530/rep.1.00294 · Cited by 197 · see citing works
Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders
Busbee, P. B., Rouse, M. D., Nagarkatti, M., & Nagarkatti, P. S. (2013) · Nutrition Reviews · doi:10.1111/nure.12024 · Cited by 187 · see citing works
The Aryl Hydrocarbon Receptor sans Xenobiotics: Endogenous Function in Genetic Model Systems
McMillan, B. J., & Bradfield, C. A. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.037259 · Cited by 177 · see citing works
Vyhlídalová, B., Krasulová, K., Pečinková, P., Marcalíková, A., Vrzal, R., Zemánková, L., Vančo, J., Trávnı́ček, Z., Vondráček, J., Karasová, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072614 · Cited by 170 · see citing works
The Aryl Hydrocarbon Receptor and Tumor Immunity
Xue, P., Fu, J., & Zhou, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00286 · Cited by 162 · see citing works
Liang, C., Xia, J., Dong, L., Li, X. O., Yao, Q., & Gao, J. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.04.040 · Cited by 152 · see citing works
Karchner, S. I., Franks, D. G., & Hahn, M. E. (2005) · Biochemical Journal · doi:10.1042/bj20050713 · Cited by 151 · see citing works
Guengerich, F. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_9 · Cited by 150 · see citing works
AhR and ARNT modulate ER signaling
Swedenborg, E., & Pongratz, I. (2009) · Toxicology · doi:10.1016/j.tox.2009.09.007 · Cited by 146 · see citing works
Role of the aryl hydrocarbon receptor in drug metabolism
Ramadoss, P., Marcus, C. B., & Perdew, G. H. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.1.9 · Cited by 144 · see citing works
Modulation of benzo[a]pyrene–DNA adduct formation by CYP1 inducer and inhibitor
Shiizaki, K., Kawanishi, M., & Yagi, T. (2017) · Genes and Environment · doi:10.1186/s41021-017-0076-x · Cited by 142 · see citing works
Moon, M. J., Lee, S. K., Lee, J., Song, W. K., Kim, S. W., Kim, J. I., Cho, C., Choi, S. J., & Kim, Y. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.08.008 · Cited by 135 · see citing works
Singh, N. P., Singh, U. P., Rouse, M. D., Zhang, J., Chatterjee, S., Nagarkatti, P. S., & Nagarkatti, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501727 · Cited by 134 · see citing works
Role of AHR Ligands in Skin Homeostasis and Cutaneous Inflammation
Fernández‐Gallego, N., Sánchez‐Madrid, F., & Cibrián, D. (2021) · Cells · doi:10.3390/cells10113176 · Cited by 135 · see citing works
Choi, H. S., Kim, J. K., Cho, E. H., Kim, Y. C., Kim, J. I., & Kim, S. W. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01087-8 · Cited by 131 · see citing works
Kawajiri, K., & Fujii‐Kuriyama, Y. (2016) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.16-0092 · Cited by 130 · see citing works
Guo, B., Bian, Z., Qiu, H.-C., Wang, Y., & Wang, Y. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13414 · Cited by 132 · see citing works
Cell Density Regulates Intracellular Localization of Aryl Hydrocarbon Receptor
Ikuta, T., Kobayashi, Y., & Kawajiri, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310492200 · Cited by 125 · see citing works
Hrycay, E. G., & Bandiera, S. M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16009-2_1 · Cited by 124 · see citing works
Rui, L., Reardon, K. F., & Wood, T. K. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1698-z · Cited by 125 · see citing works
Takamura, T., Harama, D., Fukumoto, S., Nakamura, Y., Shimokawa, N., Ishimaru, K., Ikegami, S., Makino, S., Kitamura, M., & Nakao, A. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2010.165 · Cited by 123 · see citing works
Smirnova, A. V., Wincent, E., Bergander, L. V., Alsberg, T. E., Bergman, J., Rannug, A., & Rannug, U. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00416 · Cited by 122 · see citing works
Timing is everything: Consequences of transient and sustained AhR activity
Mitchell, K. A., & Elferink, C. J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.028 · Cited by 120 · see citing works
Microarray analysis of the AHR system: Tissue-specific flexibility in signal and target genes
Frericks, M., Meissner, M., & Esser, C. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.01.014 · Cited by 121 · see citing works
Rannug, A., & Rannug, U. (2018) · Critical Reviews in Toxicology · doi:10.1080/10408444.2018.1493086 · Cited by 119 · see citing works
Kawai, S., Iijima, H., Shinzaki, S., Hiyama, S., Yamaguchi, T., Araki, M., Iwatani, S., Shiraishi, E., Mukai, A., Inoue, T., et al. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1292-z · Cited by 116 · see citing works
Sethi, G., Ahn, K. S., Sandur, S. K., Lin, X., Chaturvedi, M. M., & Aggarwal, B. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602627200 · Cited by 115 · see citing works
Mayser, P., & Gaitanis, G. (2010) · Springer eBooks · doi:10.1007/978-3-642-03616-3_4 · Cited by 113 · see citing works
Rouse, M. D., Singh, N. P., Nagarkatti, P. S., & Nagarkatti, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12205 · Cited by 111 · see citing works
Mukai, M., & Tischkau, S. A. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl126 · Cited by 110 · see citing works
Pharmacological properties of indirubin and its derivatives
Lin, Y., Li, X., Huang, W., Rao, X., & Lai, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113112 · Cited by 109 · see citing works
How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression
Wang, Z., Snyder, M., Kenison, J. E., Yang, K., Lara, B., Lydell, E., Bennani, K., Novikov, O., Federico, A. N., Monti, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010387 · Cited by 107 · see citing works
Dioxins, the aryl hydrocarbon receptor and the central regulation of energy balance
Lindén, J., Lensu, S., Tuomisto, J., & Pohjanvirta, R. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.07.002 · Cited by 107 · see citing works
Henry, E. C., Bemis, J. C., Henry, O., Kende, A. S., & Gasiewicz, T. A. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.02.008 · Cited by 106 · see citing works
Denison, M. S. (2004) · Talanta · doi:10.1016/j.talanta.2004.05.032 · Cited by 106 · see citing works
Nagayoshi, H., Kakimoto, K., Takagi, S., Konishi, Y., Kajimura, K., & Matsuda, T. (2014) · Environmental Science & Technology · doi:10.1021/es503926w · Cited by 105 · see citing works
Self-citationAryl Hydrocarbon Receptor and Its Diverse Ligands and Functions: An Exposome Receptor
Larigot, L., Benoit, L., Koual, M., Tomkiewicz, C., Barouki, R., & Coumoul, X. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052220-115707 · Cited by 108 · see citing works
Medjakovic, S., & Jungbauer, A. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.10.001 · Cited by 103 · see citing works
7-Bromoindirubin-3′-oxime induces caspase-independent cell death
Ribas, J., Bettayeb, K., Ferandin, Y., Knockaert, M., Garrofé-Ochoa, X., Totzke, F., Schächtele, C., Mešter, J., Polychronopoulos, P., Magiatis, P., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209648 · Cited by 103 · see citing works
Bruner‐Tran, K. L., Gnecco, J. S., Ding, T., Glore, D. R., Pensabene, V., & Osteen, K. G. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.07.007 · Cited by 105 · see citing works
Metabolic fate of the Ah receptor ligand 6-formylindolo[3,2-b]carbazole
Bergander, L. V., Wincent, E., Rannug, A., Foroozesh, M. K., Alworth, W. L., & Rannug, U. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.08.005 · Cited by 102 · see citing works
Bock, K. W., & Köhle, C. (2009) · Biological Chemistry · doi:10.1515/bc.2009.138 · Cited by 102 · see citing works
Jonsson, E., Abrahamson, A., Brunström, B., & Brandt, I. (2006) · Aquatic Toxicology · doi:10.1016/j.aquatox.2006.06.006 · Cited by 101 · see citing works
Mulero‐Navarro, S., Pozo‐Guisado, E., Pérez-Mancera, P. A., Alvarez, A. M., Catalina‐Fernández, I., Hernández‐Nieto, E., Sáenz‐Santamaría, J., Martínez, N., Rojas, J. M., Sánchez-Garcı́a, I., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504538200 · Cited by 100 · see citing works
Zhang, S., Kim, K., Jin, U. H., Pfent, C. M., Cao, H., Amendt, B. A., Liu, X., Wilson-Robles, H. M., & Safe, S. H. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0548 · Cited by 99 · see citing works
Knockaert, M., Blondel, M., Bach, S., Leost, M., Elbi, C., Hager, G. L., Nagy, S. R., Han, D., Denison, M. S., Ffrench, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207535 · Cited by 97 · see citing works
Matsuda, S., Adachi, J., Ihara, M., Tanuma, N., Shima, H., Kakizuka, A., Ikura, M., Ikura, T., & Matsuda, T. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv967 · Cited by 93 · see citing works
Self-citationAmakura, Y., Tsutsumi, T., Sasaki, K., Nakamura, M., Yoshida, T., & Maitani, T. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.07.022 · Cited by 95 · see citing works
Aryl hydrocarbon receptor response to indigoids in vitro and in vivo
Guengerich, F. P., Martin, M. V., McCormick, W. A., Nguyen, L. P., Glover, E. A., & Bradfield, C. A. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.01.002 · Cited by 95 · see citing works
Regulation of CYP1A1 by heavy metals and consequences for drug metabolism
Anwar‐Mohamed, A., Elbekai, R. H., & El‐Kadi, A. O. S. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902918302 · Cited by 92 · see citing works
Urolithin A Is a Dietary Microbiota-Derived Human Aryl Hydrocarbon Receptor Antagonist
Muku, G. E., Murray, I. A., Espı́n, J. C., & Perdew, G. H. (2018) · Metabolites · doi:10.3390/metabo8040086 · Cited by 91 · see citing works
The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulation
Polonio, C. M., McHale, K. A., Sherr, D. H., Rubenstein, D., & Quintana, F. J. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01172-x · Cited by 98 · see citing works
Anti-inflammatory effects of the extract of indigo naturalis in human neutrophils
Lin, Y., Leu, Y., Huang, T., Wu, Y., Chung, P.-J., Pang, J. S., & Hwang, T. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.06.014 · Cited by 91 · see citing works
Wada, T., Sunaga, H., Miyata, K., Shirasaki, H., Uchiyama, Y., & Shimba, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.693655 · Cited by 92 · see citing works
Hu, P., Herrmann, R., Bednar, A., Saloupis, P., Dwyer, M. A., Yang, P., Qi, X., Thomas, R. S., Jaffe, G. J., Boulton, M. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307574110 · Cited by 89 · see citing works
Modulating AHR function offers exciting therapeutic potential in gut immunity and inflammation
Chen, Y., Wang, Y., Fu, Y., Yin, Y., & Xu, K. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01046-y · Cited by 88 · see citing works
Andrieux, L. O., Langouët, S., Fautrel, A., Ezan, F., Krauser, J. A., Savouret, J. F., Guengerich, F. P., Baffet, G., & Guillouzo, A. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.934 · Cited by 85 · see citing works
He, G., Tsutsumi, T., Zhao, B., Baston, D. S., Zhao, J., Heath‐Pagliuso, S., & Denison, M. S. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr189 · Cited by 84 · see citing works
Levine, A., Chen, L., & Elferink, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.2.461 · Cited by 84 · see citing works
Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases
Blažević, T., Heiß, E. H., Atanasov, A. G., Breuss, J. M., Dirsch, V. M., & Uhrín, P. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/654098 · Cited by 83 · see citing works
Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin
Spink, B. C., Hussain, M. M., Katz, B. H., Eisele, L. E., & Spink, D. C. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.019 · Cited by 82 · see citing works
From the Insoluble Dye Indirubin towards Highly Active, Soluble CDK2‐Inhibitors
Jautelat, R., Brumby, T., Schäfer, M., Briem, H., Eisenbrand, G., Schwahn, S., Krüger, M., Lücking, U., Prien, O., & Siemeister, G. (2005) · ChemBioChem · doi:10.1002/cbic.200400108 · Cited by 80 · see citing works
Random Mutagenesis of Human Cytochrome P450 2A6 and Screening with Indole Oxidation Products1
Nakamura, K., Martin, M. V., & Guengerich, F. P. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2569 · Cited by 80 · see citing works
Tarnow, P., Tralau, T., & Luch, A. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1569627 · Cited by 79 · see citing works
Sugihara, K., Kitamura, S., Yamada, T., Okayama, T., Ohta, S., Yamashita, K. H., Yasuda, M., Fujii‐Kuriyama, Y., Saeki, K., Matsui, S., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.066 · Cited by 77 · see citing works
Self-citationBen‐Horin, S., Salomon, N., Karampekos, G., Viazis, N., Lahat, A., Ungar, B., Eliakim, R., Kuperstein, R., Kriger-Sharabi, O., Mintz, H. R., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.05.023 · Cited by 75 · see citing works
Amakura, Y., Tsutsumi, T., Nakamura, M., Kitagawa, H., Fujino, J., Sasaki, K., TOYODA, M., Yoshida, T., & Maitani, T. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.532 · Cited by 74 · see citing works
Self-citationPotential Health-modulating Effects of Isoflavones and Metabolites via Activation of PPAR and AhR
Medjakovic, S., Mueller, M., & Jungbauer, A. (2010) · Nutrients · doi:10.3390/nu2030241 · Cited by 74 · see citing works
Induction of cytochrome P450 enzymes: a view on human in vivo findings
Hukkanen, J. (2012) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.39 · Cited by 73 · see citing works
Wang, H., Wang, Z., Wei, C., Wang, J., Xu, Y., Bai, G., Yao, Q., Zhang, L., & Chen, Y. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113652 · Cited by 70 · see citing works
Guengerich, F. P., Sorrells, J. L., Schmitt, S., Krauser, J. A., Aryal, P., & Meijer, L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030561b · Cited by 70 · see citing works
Esser, C. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.002 · Cited by 69 · see citing works
- Authors
- Adachi, J., Mori, Y., Matsui, S., Takigami, H., Fujino, J., Kitagawa, H., Miller, C. A., Kato, T., Saeki, K., & Matsuda, T.
- Affiliations
- Kyoto University (JP)
- Tulane University (US)
- Nagoya City University (JP)
- Corresponding author
- Matsuda, Tomonari
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-08
- Volume
- 276
- Issue
- 34
- Pages
- 31475-31478
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1989060543
- Cited by
- 407
- References
- 22
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 9 · 2023: 14 · 2022: 21 · 2021: 15 · 2020: 12 · 2019: 16 · 2018: 19 · 2017: 9 · 2016: 18 · 2015: 14 · 2014: 13 · 2013: 20 · 2012: 16
- FWCI
- 15.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Environmental Health Sciences (ES09055, R29ES009055)
- Topics
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Keywords
- aryl hydrocarbon receptor, indirubin, indigo, AhR ligands, human urine, endogenous ligands, 2,3,7,8-tetrachlorodibenzo-p-dioxin, xenobiotic metabolism, transcription factor signaling
- MeSH terms
- Polychlorinated Dibenzodioxins, Humans, Indigo Carmine, Indoles, Ligands, Male, Saccharomyces cerevisiae, Signal Transduction, Genes, Reporter, Receptors, Aryl Hydrocarbon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review